Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $9.90 and traded as low as $9.23. Nxera Pharma shares last traded at $9.30, with a volume of 1,465 shares.
Nxera Pharma Stock Down 4.3 %
The stock has a fifty day moving average of $10.10 and a 200 day moving average of $9.90.
About Nxera Pharma
Nxera Pharma Co, Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications.
Further Reading
- Five stocks we like better than Nxera Pharma
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Stocks Leading the U.S. Agriculture Comeback
- What does consumer price index measure?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Quiet Period Expirations Explained
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Nxera Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nxera Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
